Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system

Tools to study microbial antigen processing and presentation to human mr1-restricted t cells

Bruno Laugel, Angharad Lloyd, Erin W. Meermeier, Michael D. Crowther, Thomas R. Connor, Garry Dolton, John J. Miles, Scott R. Burrows, Marielle Gold, David Lewinsohn, Andrew K. Sewell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The nonclassical HLA molecule MHC-related protein 1 (MR1) presents metabolites of the Vitamin B synthesis pathways to mucosal-associated invariant T (MAIT) cells and other MR1-restricted T cells. This new class of Ags represents a variation on the classical paradigm of self/non-self discrimination because these T cells are activated through their TCR by small organic compounds generated during microbial Vitamin B2 synthesis. Beyond the fundamental significance, the invariant nature of MR1 across the human population is a tantalizing feature for the potential development of universal immune therapeutic and diagnostic tools. However, many aspects of MR1 Ag presentation and MR1-restricted T cell biology remain unknown, and the ubiquitous expression of MR1 across tissues and cell lines can be a confounding factor for experimental purposes. In this study, we report the development of a novel CRISPR/Cas9 genome editing lentiviral system and its use to efficiently disrupt MR1 expression in A459, THP-1, and K562 cell lines. We generated isogenic MR12/2 clonal derivatives of the A549 lung carcinoma and THP-1 monocytic cell lines and used these to study T cell responses to intracellular pathogens. We confirmed that MAIT cell clones were unable to respond to MR12/2 clones infected with bacteria whereas Ag presentation by classical and other nonclassical HLAs was unaffected. This system represents a robust and efficient method to disrupt the expression of MR1 and should facilitate investigations into the processing and presentation of MR1 Ags as well as into the biology of MAIT cells.

Original languageEnglish (US)
Pages (from-to)971-982
Number of pages12
JournalJournal of Immunology
Volume197
Issue number3
DOIs
StatePublished - Aug 1 2016

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Cell Engineering
Antigen Presentation
Proteins
T-Lymphocytes
Cell Line
Clone Cells
Vitamin B Complex
K562 Cells
Riboflavin
Cell Biology

ASJC Scopus subject areas

  • Immunology

Cite this

Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system : Tools to study microbial antigen processing and presentation to human mr1-restricted t cells. / Laugel, Bruno; Lloyd, Angharad; Meermeier, Erin W.; Crowther, Michael D.; Connor, Thomas R.; Dolton, Garry; Miles, John J.; Burrows, Scott R.; Gold, Marielle; Lewinsohn, David; Sewell, Andrew K.

In: Journal of Immunology, Vol. 197, No. 3, 01.08.2016, p. 971-982.

Research output: Contribution to journalArticle

Laugel, Bruno ; Lloyd, Angharad ; Meermeier, Erin W. ; Crowther, Michael D. ; Connor, Thomas R. ; Dolton, Garry ; Miles, John J. ; Burrows, Scott R. ; Gold, Marielle ; Lewinsohn, David ; Sewell, Andrew K. / Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system : Tools to study microbial antigen processing and presentation to human mr1-restricted t cells. In: Journal of Immunology. 2016 ; Vol. 197, No. 3. pp. 971-982.
@article{89f50405adad4881ac922cf43093b297,
title = "Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system: Tools to study microbial antigen processing and presentation to human mr1-restricted t cells",
abstract = "The nonclassical HLA molecule MHC-related protein 1 (MR1) presents metabolites of the Vitamin B synthesis pathways to mucosal-associated invariant T (MAIT) cells and other MR1-restricted T cells. This new class of Ags represents a variation on the classical paradigm of self/non-self discrimination because these T cells are activated through their TCR by small organic compounds generated during microbial Vitamin B2 synthesis. Beyond the fundamental significance, the invariant nature of MR1 across the human population is a tantalizing feature for the potential development of universal immune therapeutic and diagnostic tools. However, many aspects of MR1 Ag presentation and MR1-restricted T cell biology remain unknown, and the ubiquitous expression of MR1 across tissues and cell lines can be a confounding factor for experimental purposes. In this study, we report the development of a novel CRISPR/Cas9 genome editing lentiviral system and its use to efficiently disrupt MR1 expression in A459, THP-1, and K562 cell lines. We generated isogenic MR12/2 clonal derivatives of the A549 lung carcinoma and THP-1 monocytic cell lines and used these to study T cell responses to intracellular pathogens. We confirmed that MAIT cell clones were unable to respond to MR12/2 clones infected with bacteria whereas Ag presentation by classical and other nonclassical HLAs was unaffected. This system represents a robust and efficient method to disrupt the expression of MR1 and should facilitate investigations into the processing and presentation of MR1 Ags as well as into the biology of MAIT cells.",
author = "Bruno Laugel and Angharad Lloyd and Meermeier, {Erin W.} and Crowther, {Michael D.} and Connor, {Thomas R.} and Garry Dolton and Miles, {John J.} and Burrows, {Scott R.} and Marielle Gold and David Lewinsohn and Sewell, {Andrew K.}",
year = "2016",
month = "8",
day = "1",
doi = "10.4049/jimmunol.1501402",
language = "English (US)",
volume = "197",
pages = "971--982",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system

T2 - Tools to study microbial antigen processing and presentation to human mr1-restricted t cells

AU - Laugel, Bruno

AU - Lloyd, Angharad

AU - Meermeier, Erin W.

AU - Crowther, Michael D.

AU - Connor, Thomas R.

AU - Dolton, Garry

AU - Miles, John J.

AU - Burrows, Scott R.

AU - Gold, Marielle

AU - Lewinsohn, David

AU - Sewell, Andrew K.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The nonclassical HLA molecule MHC-related protein 1 (MR1) presents metabolites of the Vitamin B synthesis pathways to mucosal-associated invariant T (MAIT) cells and other MR1-restricted T cells. This new class of Ags represents a variation on the classical paradigm of self/non-self discrimination because these T cells are activated through their TCR by small organic compounds generated during microbial Vitamin B2 synthesis. Beyond the fundamental significance, the invariant nature of MR1 across the human population is a tantalizing feature for the potential development of universal immune therapeutic and diagnostic tools. However, many aspects of MR1 Ag presentation and MR1-restricted T cell biology remain unknown, and the ubiquitous expression of MR1 across tissues and cell lines can be a confounding factor for experimental purposes. In this study, we report the development of a novel CRISPR/Cas9 genome editing lentiviral system and its use to efficiently disrupt MR1 expression in A459, THP-1, and K562 cell lines. We generated isogenic MR12/2 clonal derivatives of the A549 lung carcinoma and THP-1 monocytic cell lines and used these to study T cell responses to intracellular pathogens. We confirmed that MAIT cell clones were unable to respond to MR12/2 clones infected with bacteria whereas Ag presentation by classical and other nonclassical HLAs was unaffected. This system represents a robust and efficient method to disrupt the expression of MR1 and should facilitate investigations into the processing and presentation of MR1 Ags as well as into the biology of MAIT cells.

AB - The nonclassical HLA molecule MHC-related protein 1 (MR1) presents metabolites of the Vitamin B synthesis pathways to mucosal-associated invariant T (MAIT) cells and other MR1-restricted T cells. This new class of Ags represents a variation on the classical paradigm of self/non-self discrimination because these T cells are activated through their TCR by small organic compounds generated during microbial Vitamin B2 synthesis. Beyond the fundamental significance, the invariant nature of MR1 across the human population is a tantalizing feature for the potential development of universal immune therapeutic and diagnostic tools. However, many aspects of MR1 Ag presentation and MR1-restricted T cell biology remain unknown, and the ubiquitous expression of MR1 across tissues and cell lines can be a confounding factor for experimental purposes. In this study, we report the development of a novel CRISPR/Cas9 genome editing lentiviral system and its use to efficiently disrupt MR1 expression in A459, THP-1, and K562 cell lines. We generated isogenic MR12/2 clonal derivatives of the A549 lung carcinoma and THP-1 monocytic cell lines and used these to study T cell responses to intracellular pathogens. We confirmed that MAIT cell clones were unable to respond to MR12/2 clones infected with bacteria whereas Ag presentation by classical and other nonclassical HLAs was unaffected. This system represents a robust and efficient method to disrupt the expression of MR1 and should facilitate investigations into the processing and presentation of MR1 Ags as well as into the biology of MAIT cells.

UR - http://www.scopus.com/inward/record.url?scp=84979581117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979581117&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1501402

DO - 10.4049/jimmunol.1501402

M3 - Article

VL - 197

SP - 971

EP - 982

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -